KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Shares Issued (2016 - 2025)

Historic Shares Issued for Arbutus Biopharma (ABUS) over the last 16 years, with Q3 2025 value amounting to $794000.0.

  • Arbutus Biopharma's Shares Issued fell 5006.29% to $794000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 1143.29%. This contributed to the annual value of $7.5 million for FY2024, which is 129757.01% up from last year.
  • According to the latest figures from Q3 2025, Arbutus Biopharma's Shares Issued is $794000.0, which was down 5006.29% from $453000.0 recorded in Q2 2025.
  • Arbutus Biopharma's 5-year Shares Issued high stood at $2.7 million for Q1 2025, and its period low was -$115000.0 during Q4 2021.
  • Over the past 5 years, Arbutus Biopharma's median Shares Issued value was $453000.0 (recorded in 2025), while the average stood at $961133.3.
  • As far as peak fluctuations go, Arbutus Biopharma's Shares Issued plummeted by 10057.0% in 2021, and later skyrocketed by 319130.43% in 2024.
  • Over the past 5 years, Arbutus Biopharma's Shares Issued (Quarter) stood at -$115000.0 in 2021, then surged by 238.26% to $159000.0 in 2022, then plummeted by 128.93% to -$46000.0 in 2023, then soared by 3191.3% to $1.4 million in 2024, then crashed by 44.16% to $794000.0 in 2025.
  • Its last three reported values are $794000.0 in Q3 2025, $453000.0 for Q2 2025, and $2.7 million during Q1 2025.